ZVIA Should I Buy
-
$
0.000
0.000(0.000%)
At close0.000(0.000%)Aft-market
ET
Zevia PBC is not a strong buy at the moment for a beginner investor with a long-term strategy. The stock's weak financial performance, mixed analyst sentiment, and lack of significant trading signals suggest limited upside potential in the near term. While the Cardi B partnership is a positive catalyst, it is not enough to offset the broader challenges the company faces.
The MACD is positive and expanding, indicating a potential upward momentum. However, the RSI is neutral, and the moving averages are bearish, with the SMA_200 above SMA_20 and SMA_5. The stock is trading near its support level of 1.158, but overall, the technical indicators do not strongly support a buy decision.
The partnership with Cardi B as a shareholder and brand ambassador is a significant marketing move aimed at increasing brand visibility and cultural relevance. The upcoming marketing campaign in Summer 2026 could boost consumer interest.
Weak financial performance in Q4 2025, with declining revenue (-4.03% YoY), net income (-77.25% YoY), and EPS (-80.00% YoY). Analysts have lowered price targets, and the stock lacks strong trading sentiment or significant insider/hedge fund activity.
In Q4 2025, revenue dropped to $37.87M (-4.03% YoY), net income fell to -$1.31M (-77.25% YoY), and EPS declined to -$0.02 (-80.00% YoY). Gross margin also decreased to 47.27% (-2.50% YoY), indicating ongoing financial struggles.
Analysts have mixed views. Morgan Stanley lowered the price target to $1.75 and maintains an Equal Weight rating. Telsey Advisory lowered the price target to $5 but keeps an Outperform rating, citing progress in the company's turnaround efforts. Goldman Sachs reduced the price target to $3 and maintains a Neutral rating.
